Pfizer announced that it will cut R&D jobs and abandon its research efforts in the areas of cardiovascular diseases, cholesterol management, osteoporosis, anemia and liver and muscle diseases. The co
read more » Discuss Add this link to...Bury Add to:
| Bookmarks
Bristol-Myers Squibb (BMS) made a presentation this morning at the Credit Suisse Healthcare Conference that showed the company plans on saving an additional $2.5 billion in “productivity initiatives.
read more » Discuss Add this link to...Bury Add to:
| Bookmarks